| Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity KA Ryan, KR Bewley, SA Fotheringham, GS Slack, P Brown, Y Hall, ... Nature communications 12 (1), 81, 2021 | 161 | 2021 |
| Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 131 | 2021 |
| Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... Nature Communications 12 (1), 1260, 2021 | 121 | 2021 |
| Rapid report: Early demand, profiles and concerns of mental health users during the coronavirus (COVID-19) pandemic N Titov, L Staples, R Kayrouz, S Cross, E Karin, K Ryan, B Dear, ... Internet Interventions 21, 100327, 2020 | 88 | 2020 |
| Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model PC Proud, D Tsitoura, RJ Watson, BY Chua, MJ Aram, KR Bewley, ... EBioMedicine 63, 2021 | 86 | 2021 |
| COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models A Conforti, E Marra, F Palombo, G Roscilli, M Ravà, V Fumagalli, A Muzi, ... Molecular Therapy 30 (1), 311-326, 2022 | 57* | 2022 |
| Intranasal infection of ferrets with SARS-CoV-2 as a model for asymptomatic human infection HE Everett, FZX Lean, AMP Byrne, PM van Diemen, S Rhodes, J James, ... Viruses 13 (1), 113, 2021 | 57 | 2021 |
| mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection S Rauch, K Gooch, Y Hall, FJ Salguero, MJ Dennis, FV Gleeson, D Harris, ... Biorxiv, 2020.12. 23.424138, 2020 | 47 | 2020 |
| Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir AC Marriott, BK Dove, CJ Whittaker, C Bruce, KA Ryan, TJ Bean, ... PloS one 9 (4), e94090, 2014 | 46 | 2014 |
| Procedures for risk management and a review of crisis referrals from the MindSpot Clinic, a national service for the remote assessment and treatment of anxiety and depression O Nielssen, BF Dear, LG Staples, R Dear, K Ryan, C Purtell, N Titov BMC psychiatry 15, 1-6, 2015 | 43 | 2015 |
| Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge KA Ryan, KR Bewley, SA Fotheringham, P Brown, Y Hall, AC Marriott, ... BioRxiv, 2020.05. 29.123810, 2020 | 42 | 2020 |
| Rapid report 2: Symptoms of anxiety and depression during the first 12 weeks of the Coronavirus (COVID-19) pandemic in Australia L Staples, O Nielssen, R Kayrouz, S Cross, E Karin, K Ryan, B Dear, ... Internet Interventions 22, 100351, 2020 | 40 | 2020 |
| Factors associated with treatment uptake, completion, and subsequent symptom improvement in a national digital mental health service SP Cross, E Karin, LG Staples, MA Bisby, K Ryan, G Duke, O Nielssen, ... Internet Interventions 27, 100506, 2022 | 28 | 2022 |
| Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza KE Gooch, AC Marriott, KA Ryan, P Yeates, GS Slack, PJ Brown, ... Scientific reports 9 (1), 2617, 2019 | 28 | 2019 |
| Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung KA Ryan, GS Slack, AC Marriott, JA Kane, CJ Whittaker, NJ Silman, ... PloS one 13 (9), e0202675, 2018 | 27 | 2018 |
| Influenza A virus challenge models in cynomolgus macaques using the authentic inhaled aerosol and intra-nasal routes of infection AC Marriott, M Dennis, JA Kane, KE Gooch, G Hatch, S Sharpe, ... PLoS One 11 (6), e0157887, 2016 | 24 | 2016 |
| ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models T Lambe, AJ Spencer, KM Thomas, KE Gooch, S Thomas, AD White, ... Communications biology 4 (1), 915, 2021 | 20 | 2021 |
| Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques KR Bewley, K Gooch, KM Thomas, S Longet, N Wiblin, L Hunter, K Chan, ... Science advances 7 (37), eabg7996, 2021 | 19 | 2021 |
| One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model KE Gooch, TRF Smith, FJ Salguero, SA Fotheringham, RJ Watson, ... Vaccine 39 (34), 4885-4894, 2021 | 19 | 2021 |
| Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model PAC Wing, M Prange-Barczynska, A Cross, S Crotta, C Orbegozo Rubio, ... PLoS Pathogens 18 (9), e1010807, 2022 | 18 | 2022 |
